Trading Signals: EDIT Stock Price Prediction and Forecast (Wed. Feb. 3, 2016 - Fri. Dec. 22, 2023)(EDITAS MEDICIN)
| EDIT latest price $39.7900 (-5.7%) ($39.7900 - $39.7900) on Fri. Mar. 26, 2021. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 5.62% (three month average) | RSI | 53 | Latest Price | $39.7900(-5.7%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | EDIT declines -2.3% a day on average for past five trading days. | Weekly Trend | EDIT declines -2.4% a week on average for past two weeks. | Market Behavior | Broad based rally for large cap. Broad based rally for small cap. | Correlated ETFs | Broad market will support EDIT advance at 0% a week (0% probability) IBB(66%) IWO(61%) IWC(59%) IBUY(58%) IPO(56%) | Factors Impacting EDIT price | EDIT will decline at least -2.81% in a week (0% probabilities). VIXM(-31%) UUP(-16%) VXX(-13%) TBT(-7%) IGOV(-3%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -2.81% (StdDev 5.62%) | Hourly BBV | -1.1 () | Intraday Trend | 0% | | | |
|
1 - 5 Day Possible Target | $32.05(-19.45%) | Resistance Level | $44.45 | 5 Day Moving Average | $43.42(-8.36%) | 10 Day Moving Average | $44.4(-10.38%) | 20 Day Moving Average | $44.45(-10.48%) | To recent high | -56.2% | To recent low | 0% | Market Cap | $2.471b | | | | Editas Medicine, Inc. engages in the development and commercialization of genome editing technology. Its technology includes clustered, regularly interspaced short palindromic repeats (CRISPR), and CRISPR associated protein 9 (Cas9). The company was founded by Feng Zhang, Jennifer A. Doudna, George McDonald Church, J. Keith Joung and David R. Liu in September 2013 and is headquartered in Cambridge, MA. |